Capstone Asset Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$710K Sell
47,450
-2,080
-4% -$27.8K 0.02% 714
2017
Q1
$472K Sell
49,530
-3,430
-6% -$29K 0.01% 965
2016
Q4
$469K Buy
52,960
+590
+1% +$5.3K 0.01% 975
2016
Q3
$449K Buy
52,370
+590
+1% +$4.67K 0.01% 1036
2016
Q2
$413K Buy
51,780
+7,650
+17% +$59.5K 0.01% 1069
2016
Q1
$386K Sell
44,130
-1,700
-4% -$14.1K 0.01% 1092
2015
Q4
$429K Buy
45,830
+600
+1% +$5.2K 0.01% 1024
2015
Q3
$436K Buy
+45,230
New +$477K 0.01% 1001

Other funds holding MDXG

Capstone Asset Management's MDXG Position: Q2 2017 in Review

Capstone Asset Management reduced its MiMedx Group (MDXG) stake by 4.2% in Q2 2017, selling an estimated $27.8K and leaving 47,450 shares worth $710K. The position accounts for 0.02% of the portfolio, ranked #714.

Capstone Asset Management first reported a position in MDXG in Q3 2015 and has held it in 8 quarters since. 209 funds tracked by Wall St. Rank hold MDXG as of Q2 2017.

  • Capstone Asset Management held 47,450 shares of MiMedx Group worth $710K as of Q2 2017.
  • Capstone Asset Management sold 2,080 MiMedx Group shares in Q2 2017, an estimated $27.8K.
  • MiMedx Group made up 0.02% of Capstone Asset Management's portfolio in Q2 2017, its #714 holding.
  • Capstone Asset Management first reported a position in MiMedx Group in Q3 2015 and has held it in 8 quarters since.
  • 209 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.